Rodney Snow, MD
Endocrinology, Diabetes & Metabolism · Nashville, TNNPI 1770798506
Payments from drug & device makers
Across 1,041 payments — averaging $180.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$95K
- Mannkind Corporation$34K
- Medtronic$21K
- Shire North American Group Inc$15K
- Insulet Corporation$7K
- Zealand Pharma US, Inc.$3K
- plus $11K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 92 | $95,439 |
| Mannkind Corporation | 318 | $34,460 |
| Medtronic | 51 | $21,482 |
| Shire North American Group Inc | 23 | $15,046 |
| Insulet Corporation | 43 | $7,375 |
| Zealand Pharma US, Inc. | 7 | $3,219 |
| Novo Nordisk | 89 | $1,896 |
| Lilly USA, LLC | 87 | $1,783 |
| Abbott | 105 | $1,559 |
| Cequr Corporation | 4 | $944 |
| Boehringer Ingelheim | 40 | $861 |
| Xeris Pharmaceuticals, Inc. | 25 | $539 |
| Companion Medical, Inc. | 1 | $500 |
| Amgen | 36 | $487 |
| Sanofi-aventis U.S. LLC | 24 | $438 |
| BETA Bionics, Inc. | 20 | $396 |
| Tandem Diabetes Care, Inc. | 9 | $383 |
| Sequel Med Tech, LLC | 8 | $274 |
| Amneal Pharmaceuticals LLC | 12 | $215 |
| Corcept Therapeutics | 10 | $197 |
| AstraZeneca | 4 | $193 |
| Dexcom, Inc. | 4 | $135 |
| IBSA Pharma Inc. | 5 | $97 |
| AbbVie | 6 | $90 |
| Amphastar Pharmaceuticals, Inc. | 4 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $75 |
| Ascensia Diabetes Care US Inc. | 3 | $70 |
| Bigfoot Biomedical Inc | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Senseonics, Incorporated | 1 | $24 |
| GSK | 1 | $21 |
| Halozyme Inc | 1 | $19 |
| Nevro Corp. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $6 |
How this compares
$188,371 in reported general payments places this provider in the 80th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Nashville
- Stephen SharpNashville$25.9M
- Kathryn DahirNashville$11M
- Craig WierumNashville$1.7M
- Terri JerkinsNashville$1.2M
- Shichun BaoNashville$735K
- Michael MayNashville$689K
- Michael CarlsonNashville$381K
- Kevin NiswenderNashville$100K
- Howard BaumNashville$81K
- Annis MarneyNashville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.